• 7043 malaria professionals are enjoying the free benefits of MalariaWorld today

Society Meeting Paper: Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants

Author(s): 
Matthew Cairns, Roly Gosling, Samwel Gesase, Jacklin Mosha, Brian Greenwood, Daniel Chandramohan
Reference: 
Transactions of the Royal Society of Tropical Medicine and Hygiene, Volume 103, Issue 12, December 2009, Pages 1199-1201, doi:10.1016/j.trstmh.2009.06.007
Contact email: 
matthew.cairns@lshtm.ac.uk

Intermittent preventive treatment in infants (IPTi) is an effective and safe malaria control strategy. However, it remains unclear what antimalarials should be used to replace sulfadoxine-pyrimethamine (SP) when and where SP is no longer an effective drug for IPTi. Work recently conducted in Tanzania, combined with the findings of previous studies, indicates that IPTi is essentially intermittent chemoprophylaxis; consequently, long-acting antimalarials that provide a long period of post-treatment prophylaxis will be the most effective alternative to SP. However, because of concerns about development of drug resistance, new combinations of long-acting drugs are urgently needed.